产品标题 产品货号 产品规格 厂家
Phosphoribosyl pyrophosphate synthetase 1 (PRPS1) from ORIGENE TECHNOLOGIESLY400979100 ugORIGENE TECHNOLOGIES
Phosphoribosyl pyrophosphate synthetase 2 (PRPS2), transcript variant 1 from ORIGENE TECHNOLOGIESLY422014100 ugORIGENE TECHNOLOGIES
Phosphoribosyl pyrophosphate synthetase 2 (PRPS2), transcript variant 2 from ORIGENE TECHNOLOGIESLY419123100 ugORIGENE TECHNOLOGIES
Phosphoribosyl transferase domain containing 1 (PRTFDC1) from ORIGENE TECHNOLOGIESLY412622100 ugORIGENE TECHNOLOGIES
Headcase homolog (Drosophila) (HECA) from ORIGENE TECHNOLOGIESLY414114100 ugORIGENE TECHNOLOGIES
Heart and neural crest derivatives expressed 1 (HAND1) from ORIGENE TECHNOLOGIESLY417727100 ugORIGENE TECHNOLOGIES
Heart and neural crest derivatives expressed 2 (HAND2) from ORIGENE TECHNOLOGIESLY411848100 ugORIGENE TECHNOLOGIES
Human BRCA2 and CDKN1A interacting protein (BCCIP), transcript variant B from ORIGENE TECHNOLOGIESTP30306120 ugORIGENE TECHNOLOGIES
Human BRCA1 associated protein (BRAP) from ORIGENE TECHNOLOGIESTP76034950 ugORIGENE TECHNOLOGIES
Human BRCA1 associated protein-1 (ubiquitin carboxy-terminal hydrolase) (BAP1) from ORIGENE TECHNOLOGIESTP30037820 ugORIGENE TECHNOLOGIES
Cytochrome c oxidase subunit IV isoform 1 (COX4I1) from ORIGENE TECHNOLOGIESLY400701100 ugORIGENE TECHNOLOGIES
Cytochrome c oxidase subunit IV isoform 2 (lung) (COX4I2), nuclear gene encoding mitochondrial protein from ORIGENE TECHNOLOGIESLY410005100 ugORIGENE TECHNOLOGIES
Cytochrome c oxidase subunit Va (COX5A), nuclear gene encoding mitochondrial protein from ORIGENE TECHNOLOGIESLY418109100 ugORIGENE TECHNOLOGIES
Cytochrome c oxidase subunit Vb (COX5B) from ORIGENE TECHNOLOGIESLY419690100 ugORIGENE TECHNOLOGIES
Cytochrome c oxidase subunit VIa polypeptide 1 (COX6A1), nuclear gene encoding mitochondrial protein from ORIGENE TECHNOLOGIESLY401392100 ugORIGENE TECHNOLOGIES
Cytochrome c oxidase subunit VIa polypeptide 2 (COX6A2), nuclear gene encoding mitochondrial protein from ORIGENE TECHNOLOGIESLY417442100 ugORIGENE TECHNOLOGIES
Cytochrome c oxidase subunit VIb polypeptide 1 (ubiquitous) (COX6B1), nuclear gene encoding mitochondrial protein from ORIGENE TECHNOLOGIESLY419691100 ugORIGENE TECHNOLOGIES
Cytochrome c oxidase subunit VIc (COX6C) from ORIGENE TECHNOLOGIESLY418028100 ugORIGENE TECHNOLOGIES
Cytochrome c oxidase subunit VIb polypeptide 2 (testis) (COX6B2) from ORIGENE TECHNOLOGIESLY408248100 ugORIGENE TECHNOLOGIES
Cytochrome c oxidase subunit VIIa polypeptide 2 like (COX7A2L), nuclear gene encoding mitochondrial protein from ORIGENE TECHNOLOGIESLY417801100 ugORIGENE TECHNOLOGIES
Cytochrome c oxidase subunit VIIa polypeptide 2 (liver) (COX7A2), nuclear gene encoding mitochondrial protein, transcript variant 1 from ORIGENE TECHNOLOGIESLY419693100 ugORIGENE TECHNOLOGIES
Cytochrome c oxidase subunit VIIb2 (COX7B2) from ORIGENE TECHNOLOGIESLY408887100 ugORIGENE TECHNOLOGIES
Cytochrome c oxidase subunit VIIc (COX7C), nuclear gene encoding mitochondrial protein from ORIGENE TECHNOLOGIESLY419695100 ugORIGENE TECHNOLOGIES
Cytochrome c oxidase subunit VIIa polypeptide 1 (muscle) (COX7A1) from ORIGENE TECHNOLOGIESLY419692100 ugORIGENE TECHNOLOGIES
Phosphoprotein associated with glycosphingolipid microdomains 1 (PAG1) from ORIGENE TECHNOLOGIESLY402686100 ugORIGENE TECHNOLOGIES
Human Ovary; Adenocarcinoma of ovary, papillary serous, metastatic from ORIGENE TECHNOLOGIESCS7004035x5umORIGENE TECHNOLOGIES
Human Ovary; Adenocarcinoma of ovary, papillary serous, metastatic from ORIGENE TECHNOLOGIESCS7022625x5umORIGENE TECHNOLOGIES
Human Ovary; Adenocarcinoma of ovary, papillary serous, metastatic from ORIGENE TECHNOLOGIESCS7004025x5umORIGENE TECHNOLOGIES
Human Ovary; Adenocarcinoma of ovary, papillary serous, metastatic from ORIGENE TECHNOLOGIESCS7033245x5umORIGENE TECHNOLOGIES
Human Ovary; Adenocarcinoma of ovary, papillary serous, metastatic from ORIGENE TECHNOLOGIESCS7033255x5umORIGENE TECHNOLOGIES
Human Ovary; Adenocarcinoma of ovary, papillary serous, metastatic from ORIGENE TECHNOLOGIESCS7066135x5umORIGENE TECHNOLOGIES
Human Ovary; Adenocarcinoma of ovary, papillary serous, metastatic from ORIGENE TECHNOLOGIESCS7108655x5umORIGENE TECHNOLOGIES
Human Ovary; Adenocarcinoma of ovary, papillary serous, metastatic from ORIGENE TECHNOLOGIESCS8016725x5umORIGENE TECHNOLOGIES
Human Ovary; Adenocarcinoma of ovary, papillary serous, metastatic from ORIGENE TECHNOLOGIESCS8058525x5umORIGENE TECHNOLOGIES
Human Ovary; Adenocarcinoma of ovary, papillary serous, metastatic from ORIGENE TECHNOLOGIESCS8044595x5umORIGENE TECHNOLOGIES
Human Ovary; Adenocarcinoma of ovary, papillary serous, metastatic from ORIGENE TECHNOLOGIESCS8063505x5umORIGENE TECHNOLOGIES
Human Ovary; Adenocarcinoma of ovary, papillary serous, metastatic from ORIGENE TECHNOLOGIESCS8064845x5umORIGENE TECHNOLOGIES
Human Ovary; Adenocarcinoma of ovary, papillary serous, metastatic from ORIGENE TECHNOLOGIESCS8064865x5umORIGENE TECHNOLOGIES
Human Ovary; Adenocarcinoma of ovary, papillary serous, metastatic from ORIGENE TECHNOLOGIESCS8064855x5umORIGENE TECHNOLOGIES
Human Ovary; Adenocarcinoma of ovary, papillary serous, metastatic from ORIGENE TECHNOLOGIESCS8069825x5umORIGENE TECHNOLOGIES
Human Ovary; Adenocarcinoma of ovary, papillary serous, metastatic from ORIGENE TECHNOLOGIESCS8069835x5umORIGENE TECHNOLOGIES
Human Ovary; Adenocarcinoma of ovary, papillary serous, metastatic from ORIGENE TECHNOLOGIESCS8069845x5umORIGENE TECHNOLOGIES
Human Ovary; Adenocarcinoma of ovary, papillary serous, metastatic from ORIGENE TECHNOLOGIESCS8073685x5umORIGENE TECHNOLOGIES
Human Ovary; Adenocarcinoma of ovary, papillary serous, metastatic from ORIGENE TECHNOLOGIESCS8078785x5umORIGENE TECHNOLOGIES
Human Ovary; Adenocarcinoma of ovary, papillary serous, metastatic from ORIGENE TECHNOLOGIESCS8073695x5umORIGENE TECHNOLOGIES
Human Ovary; Adenocarcinoma of ovary, papillary serous, metastatic from ORIGENE TECHNOLOGIESCS8088035x5umORIGENE TECHNOLOGIES
Human Ovary; Adenocarcinoma of ovary, papillary serous, metastatic from ORIGENE TECHNOLOGIESCS8085735x5umORIGENE TECHNOLOGIES
Human Ovary; Adenocarcinoma of ovary, papillary serous, metastatic from ORIGENE TECHNOLOGIESCS8088045x5umORIGENE TECHNOLOGIES
Human Ovary; Adenocarcinoma of ovary, papillary serous, metastatic from ORIGENE TECHNOLOGIESCS8103265x5umORIGENE TECHNOLOGIES
Human Ovary; Adenocarcinoma of ovary, papillary serous, metastatic from ORIGENE TECHNOLOGIESCS8119775x5umORIGENE TECHNOLOGIES
 |< < 5104 5105 5106 5107 5108 5109 5110 5111 5112 > >| 第 5104/6274 页